SAUNDERS; LAURA
Patent Applications and Registrations
Patent applications and USPTO patent grants for SAUNDERS; LAURA.The latest application filed is for "novel anti-bmpr1b antibodies and methods of use".
Company Profile
17.37.49
- SAUNDERS; LAURA - SAN FRANCISCO CA
Patent Activity
| Patent | Date |
|---|---|
| Novel Anti-bmpr1b Antibodies And Methods Of Use App 20210261670 - ROY; SOMDUTTA ; et al. | 2021-08-26 |
| Light chain variable regions Grant 11,033,634 - Stull , et al. June 15, 2 | 2021-06-15 |
| Anti-BMPR1B antibodies and methods of use Grant 10,934,359 - Roy , et al. March 2, 2 | 2021-03-02 |
| Anti Sez6 Antibodies And Methods Of Use App 20200181256 - SAUNDERS; LAURA ; et al. | 2020-06-11 |
| Dll3 Modulators And Methods Of Use App 20200138969 - Stull; Robert A. ; et al. | 2020-05-07 |
| Anti SEZ6 antibodies and methods of use Grant 10,533,051 - Saunders , et al. Ja | 2020-01-14 |
| Anti-MFI2 antibodies and methods of use Grant 10,428,156 - Williams , et al. October 1, 2 | 2019-10-01 |
| Dll3 Modulators And Methods Of Use App 20190247510 - STULL; ROBERT A. ; et al. | 2019-08-15 |
| Anti-dll3 Antibody Drug Conjugates And Methods Of Use App 20190225685 - ISSE; KUMIKO ; et al. | 2019-07-25 |
| Anti-dll3 Drug Conjugates For Treating Tumors At Risk Of Neuroendocrine Transition App 20190201542 - SAUNDERS; Laura ; et al. | 2019-07-04 |
| Anti-ascl1 Antibodies And Methods Of Use App 20190194319 - BERNSTEIN; JEFFREY ; et al. | 2019-06-27 |
| Anti-DLL3 antibodies and drug conjugates for use in melanoma Grant 10,308,721 - Williams , et al. | 2019-06-04 |
| Novel Anti-bmpr1b Antibodies And Methods Of Use App 20190153103 - ROY; SOMDUTTA ; et al. | 2019-05-23 |
| Novel Anti-tnfrsf21 Antibodies And Methods Of Use App 20190127476 - SAUNDERS; LAURA ; et al. | 2019-05-02 |
| Novel Anti-claudin Antibodies And Methods Of Use App 20190077876 - SANTAGUIDA; Marianne ; et al. | 2019-03-14 |
| Dll3 Modulators And Methods Of Use App 20190046656 - STULL; ROBERT A. ; et al. | 2019-02-14 |
| Anti-DPEP3 antibodies and methods of use Grant 10,189,910 - Saunders , et al. Ja | 2019-01-29 |
| Novel Anti-mmp16 Antibodies And Methods Of Use App 20190022242 - ROY; SOMDUTTA ; et al. | 2019-01-24 |
| Novel Sez6 Modulators And Methods Of Use App 20190022241 - Liu; David ; et al. | 2019-01-24 |
| Novel Anti-tnfsf9 Antibodies And Methods Of Use App 20190016812 - BERNSTEIN; JEFFREY ; et al. | 2019-01-17 |
| Anti-DLL3 antibody drug conjugates for treating cancer Grant 10,137,204 - Stull , et al. November 27, 2 | 2018-11-27 |
| Anti-claudin antibodies and methods of use Grant 10,053,511 - Santaguida , et al. August 21, 2 | 2018-08-21 |
| SEZ6 modulators and methods of use Grant 9,993,566 - Liu , et al. June 12, 2 | 2018-06-12 |
| Anti-DLL3 antibody drug conjugates and methods of use Grant 9,937,268 - Stull , et al. April 10, 2 | 2018-04-10 |
| Methods of making DLL3 antibody drug conjugates Grant 9,931,420 - Stull , et al. April 3, 2 | 2018-04-03 |
| Methods of delivering DLL3 antibody drug conjugates Grant 9,931,421 - Stull , et al. April 3, 2 | 2018-04-03 |
| Methods Of Delivering Dll3 Antibody Drug Conjugates App 20180036422 - STULL; ROBERT A. ; et al. | 2018-02-08 |
| Methods Of Making Dll3 Antibody Drug Conjugates App 20180036421 - STULL; ROBERT A. ; et al. | 2018-02-08 |
| Methods of delivering DLL3 antibody drug conjugates Grant 9,878,053 - Stull , et al. January 30, 2 | 2018-01-30 |
| Anti-dll3 Antibody Drug Conjugates And Methods Of Use App 20180015178 - STULL; ROBERT A. ; et al. | 2018-01-18 |
| Anti-DLL3 antibody drug conjugates Grant 9,867,887 - Stull , et al. January 16, 2 | 2018-01-16 |
| Kits containing DLL3 antibody drug conjugates Grant 9,861,708 - Stull , et al. January 9, 2 | 2018-01-09 |
| Anti-DLL3 antibody drug conjugates Grant 9,855,343 - Stull , et al. January 2, 2 | 2018-01-02 |
| Anti Sez6 Antibodies And Methods Of Use App 20170369571 - SAUNDERS; LAURA ; et al. | 2017-12-28 |
| Anti-dll3 Antibody Drug Conjugates App 20170368195 - STULL; ROBERT A. ; et al. | 2017-12-28 |
| Novel Anti-mfi2 Antibodies And Methods Of Use App 20170320960 - WILLIAMS; SAMUEL ; et al. | 2017-11-09 |
| Kits Containing Dll3 Antibody Drug Conjugates App 20170307622 - STULL; ROBERT A. ; et al. | 2017-10-26 |
| Anti-DPEP3 antibodies and methods of use Grant 9,777,071 - Saunders , et al. October 3, 2 | 2017-10-03 |
| Anti-DLL3 antibody drug conjugates for treating cancer Grant 9,775,916 - Stull , et al. October 3, 2 | 2017-10-03 |
| Dll3 Modulators And Methods Of Use App 20170274094 - STULL; ROBERT A. ; et al. | 2017-09-28 |
| Anti-DLL3 antibody drug conjugates Grant 9,770,518 - Stull , et al. September 26, 2 | 2017-09-26 |
| Methods Of Making Dll3 Antibody Drug Conjugates App 20170266314 - STULL; ROBERT A. ; et al. | 2017-09-21 |
| Anti-dll3 Antibody Drug Conjugates For Treating Cancer App 20170266315 - STULL; ROBERT A. ; et al. | 2017-09-21 |
| Methods Of Delivering Dll3 Antibody Drug Conjugates App 20170266313 - STULL; ROBERT A. ; et al. | 2017-09-21 |
| Anti-dll3 Antibody Drug Conjugates App 20170266312 - STULL; ROBERT A. ; et al. | 2017-09-21 |
| Methods of making DLL3 antibody drug conjugates Grant 9,764,042 - Stull , et al. September 19, 2 | 2017-09-19 |
| Anti SEZ6 antibodies and methods of use Grant 9,676,850 - Saunders , et al. June 13, 2 | 2017-06-13 |
| Anti-dll3 Antibodies And Drug Conjugates For Use In Melanoma App 20170137533 - WILLIAMS; Samuel ; et al. | 2017-05-18 |
| Novel Anti-dpep3 Antibodies And Methods Of Use App 20170044271 - SAUNDERS; LAURA ; et al. | 2017-02-16 |
| Novel Anti-dpep3 Antibodies And Methods Of Use App 20170029530 - SAUNDERS; Laura ; et al. | 2017-02-02 |
| Dll3 Modulators And Methods Of Use App 20170000901 - STULL; Robert A. ; et al. | 2017-01-05 |
| Anti-DLL3 antibody drug conjugates Grant 9,480,757 - Stull , et al. November 1, 2 | 2016-11-01 |
| Anti-DLL3 antibody drug conjugates Grant 9,481,727 - Stull , et al. November 1, 2 | 2016-11-01 |
| Novel Anti-claudin Antibodies And Methods Of Use App 20160289332 - SANTAGUIDA; Marianne ; et al. | 2016-10-06 |
| Novel Sez6 Modulators And Methods Of Use App 20160287720 - LIU; David ; et al. | 2016-10-06 |
| Anti-DLL3 antibody drug conjugates App 20160251431 - STULL; Robert A. ; et al. | 2016-09-01 |
| Anti-DLL3 antibody drug conjugates App 20160250348 - STULL; Robert A. ; et al. | 2016-09-01 |
| Anti-DLL3 antibody drug conjugates App 20160228571 - STULL; Robert A. ; et al. | 2016-08-11 |
| Kits Containing Dll3 Antibody Drug Conjugates App 20160158379 - Stull; Robert A. ; et al. | 2016-06-09 |
| Methods of making DLL3 antibody drug conjugates Grant 9,358,304 - Stull , et al. June 7, 2 | 2016-06-07 |
| Methods Of Delivering Dll3 Antibody Drug Conjugates App 20160151513 - Stull; Robert A. ; et al. | 2016-06-02 |
| Anti-DLL3 antibodies Grant 9,353,182 - Stull , et al. May 31, 2 | 2016-05-31 |
| Kits containing DLL3 antibody drug conjugates Grant 9,352,051 - Stull , et al. May 31, 2 | 2016-05-31 |
| Methods of delivering DLL3 antibody drug conjugates Grant 9,345,784 - Stull , et al. May 24, 2 | 2016-05-24 |
| Methods Of Making Dll3 Antibody Drug Conjugates App 20160136296 - STULL; Robert A. ; et al. | 2016-05-19 |
| Multivalent Dll3 Antibodies App 20160130331 - Stull; Robert A. ; et al. | 2016-05-12 |
| Multivalent DLL3 antibodies Grant 9,334,318 - Stull , et al. May 10, 2 | 2016-05-10 |
| Dll3 Modulators And Methods Of Use App 20160075779 - STULL; Robert A. ; et al. | 2016-03-17 |
| Anti-dll3 Antibody Drug Conjugates App 20150328332 - STULL; ROBERT A. ; et al. | 2015-11-19 |
| Anti-DLL3 antibody drug conjugates Grant 9,173,959 - Stull , et al. November 3, 2 | 2015-11-03 |
| Anti-DLL3 antibody drug conjugates and methods of use Grant 9,155,803 - Stull , et al. October 13, 2 | 2015-10-13 |
| Anti-dll3 Antibody Drug Conjugates And Methods Of Use App 20150265724 - Stull; Robert A. ; et al. | 2015-09-24 |
| Anti-DLL3 antibody drug conjugates and methods of use Grant 9,133,271 - Stull , et al. September 15, 2 | 2015-09-15 |
| Anti-DLL3 antibody drug conjugates for treating cancer Grant 9,107,961 - Stull , et al. August 18, 2 | 2015-08-18 |
| Anti-DLL3 antibody drug conjugates and methods of use Grant 9,089,616 - Stull , et al. July 28, 2 | 2015-07-28 |
| Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies Grant 9,090,683 - Stull , et al. July 28, 2 | 2015-07-28 |
| Anti-DLL3 antibodies Grant 9,089,615 - Stull , et al. July 28, 2 | 2015-07-28 |
| Anti-DLL3 antibody drug conjugates Grant 9,089,617 - Stull , et al. July 28, 2 | 2015-07-28 |
| Nucleic acid encoding DLL3 antibodies Grant 8,986,972 - Stull , et al. March 24, 2 | 2015-03-24 |
| Anti Sez6 Antibodies And Methods Of Use App 20150018531 - Saunders; Laura ; et al. | 2015-01-15 |
| Dll3 Modulators And Methods Of Use App 20140370037 - STULL; ROBERT A. ; et al. | 2014-12-18 |
| Dll3 Modulators And Methods Of Use App 20140363887 - STULL; ROBERT A. ; et al. | 2014-12-11 |
| Dll3 Modulators And Methods Of Use App 20140363455 - STULL; ROBERT A ; et al. | 2014-12-11 |
| Dll3 Modulators And Methods Of Use App 20140364593 - STULL; ROBERT A. ; et al. | 2014-12-11 |
| Dll3 Modulators And Methods Of Use App 20140364590 - STULL; ROBERT A. ; et al. | 2014-12-11 |
| Dll3 Modulators And Methods Of Use App 20140363826 - STULL; ROBERT A. ; et al. | 2014-12-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 